We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Voids PDL Antibody Patent In MedImmune Suit

Law360 (January 10, 2011, 3:34 PM EST) -- A federal judge has dealt PDL BioPharma Inc. a major blow, invalidating a patent covering the engineering of antibodies and ruling that MedImmune LLC did not violate a licensing agreement with sales of its Synagis drug.

In a ruling that could cost PDL hundreds of millions of dollars in royalties, Judge Jeremy Fogel of the U.S. District Court for the Northern District of California found on Friday that U.S. Patent Number 6,180,370 is invalid as anticipated by prior art and held that MedImmune did not violate...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.